Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

BUY
$0.31 - $0.73 $16,361 - $38,528
52,779 Added 210.78%
77,819 $31,000
Q4 2022

Feb 14, 2023

BUY
$0.27 - $5.75 $6,760 - $143,980
25,040 New
25,040 $7,000
Q2 2022

Aug 15, 2022

BUY
$0.6 - $1.14 $22,510 - $42,769
37,517 New
37,517 $30,000
Q1 2022

May 16, 2022

SELL
$0.88 - $1.37 $111,859 - $174,144
-127,113 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.27 - $2.08 $161,433 - $264,395
127,113 New
127,113 $164,000
Q4 2019

Feb 14, 2020

SELL
$1.05 - $1.66 $17,748 - $28,058
-16,903 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.2 - $12.7 $20,283 - $214,668
16,903 New
16,903 $20,000

About Xenetic Biosciences, Inc.


  • Ticker XBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,166,600
  • Market Cap $62.9M
  • Description
  • Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...
More about XBIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.